{"schema_version":"1","generated_at":"2026-10-31T22:44:20.451Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kimberly-leslie","json_url":"https://www.findmykol.com/kol/kimberly-leslie/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kimberly-leslie","name":"Kimberly Leslie","credential":"MD","specialty":"Obstetrics & Gynecology","specialty_raw":"Obstetrics & Gynecology","therapeutic_area":"Gynecologic","therapeutic_areas":["Gynecologic"],"institution":"University of New Mexico","institution_url":"https://www.findmykol.com/institution/university-of-new-mexico","city":"Albuquerque","state":"NM","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1477560423","orcid":"0000-0002-2704-8990","openalex":"A5011828487"},"summary":"Kimberly Leslie is a Gynecologic physician affiliated with University of New Mexico. OpenAlex indexes 326 publications with 7,368 citations (h-index 47); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Obstetrics & Gynecology profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Gynecologic"]},"scholarship":{"works_count":326,"cited_by_count":7368,"h_index":47,"latest_activity_year":2026,"citation_standing":{"top_percent":5,"cohort":"Obstetrics & Gynecology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00096447","title":"Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT00096447","trial_url":"https://www.findmykol.com/trial/NCT00096447"},{"nct":"NCT00027690","title":"Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT00027690","trial_url":"https://www.findmykol.com/trial/NCT00027690"}],"source":"trials"},"funding":{"award_count":3,"fiscal_years":{"first":2002,"last":2026},"rows_total":22,"shown":3,"withheld":19,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"P01CA278735","title":"Advancing Hormone Therapy for Endometrial Cancer","fiscal_year":2026,"amount_usd":"2489255","organization":"UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR","source_url":"https://reporter.nih.gov/quickSearch/P01CA278735"},{"project":"P01CA278735","title":"Evaluating promising progestins through surgical window trials in women newly diagnosed with endometrial cancer","fiscal_year":2026,"amount_usd":"489601","organization":"UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR","source_url":"https://reporter.nih.gov/quickSearch/P01CA278735"},{"project":"P01CA278735","title":"Biospecimen Core","fiscal_year":2026,"amount_usd":"156142","organization":"UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR","source_url":"https://reporter.nih.gov/quickSearch/P01CA278735"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study","year":2022,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.21.02506","status":"verified"},{"title":"Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study","year":2021,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2021.01.025","status":"verified"},{"title":"Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing","year":2021,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers13122901","status":"verified"},{"title":"Metadherin enhances vulnerability of cancer cells to ferroptosis","year":2019,"journal":"Cell Death and Disease","source_url":"https://doi.org/10.1038/s41419-019-1897-2","status":"verified"},{"title":"Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior","year":2019,"journal":"Scientific Reports","source_url":"https://doi.org/10.1038/s41598-019-54401-w","status":"verified"}],"source":"works"},"similar":[{"name":"Corey Ford","slug":"corey-ford","institution":"University of New Mexico","specialty":"Neurology","url":"https://www.findmykol.com/kol/corey-ford","json_url":"https://www.findmykol.com/kol/corey-ford/profile.json"},{"name":"Denise Lin","slug":"denise-lin","institution":"University of New Mexico","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/denise-lin","json_url":"https://www.findmykol.com/kol/denise-lin/profile.json"},{"name":"Andrew Matsumoto","slug":"andrew-matsumoto","institution":"University of New Mexico","specialty":"Dermatology","url":"https://www.findmykol.com/kol/andrew-matsumoto","json_url":"https://www.findmykol.com/kol/andrew-matsumoto/profile.json"},{"name":"Mauricio Tohen","slug":"mauricio-tohen","institution":"University of New Mexico","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/mauricio-tohen","json_url":"https://www.findmykol.com/kol/mauricio-tohen/profile.json"},{"name":"Baha Sibai","slug":"baha-sibai","institution":"McGovern Medical School at UTHealth Houston","specialty":"Maternal & Fetal Medicine","url":"https://www.findmykol.com/kol/baha-sibai","json_url":"https://www.findmykol.com/kol/baha-sibai/profile.json"},{"name":"Robert Coleman","slug":"robert-coleman","institution":"Vaniam Group","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/robert-coleman","json_url":"https://www.findmykol.com/kol/robert-coleman/profile.json"},{"name":"Kathleen Moore","slug":"kathleen-moore","institution":"University of Nebraska Medical Center","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/kathleen-moore","json_url":"https://www.findmykol.com/kol/kathleen-moore/profile.json"},{"name":"Bradley Monk","slug":"bradley-monk","institution":"Florida Cancer Specialists & Research Institute","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/bradley-monk","json_url":"https://www.findmykol.com/kol/bradley-monk/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":19,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}